Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial.
Weintraub WS, Mahoney EM, Zhang Z, Chu H, Hutton J, Buxton M, Booth J, Nugara F, Stables RH, Dooley P, Collinson J, Stuteville M, Delahunty N, Wright A, Flather MD, De Cock E. Weintraub WS, et al. Among authors: stuteville m. Heart. 2004 Jul;90(7):782-8. doi: 10.1136/hrt.2003.015057. Heart. 2004. PMID: 15201249 Free PMC article. Clinical Trial.
Two-year outcomes after deployment of XIENCE V everolimus-eluting stents in patients undergoing percutaneous coronary intervention of bifurcation lesions: a report from the SPIRIT V single arm study.
Džavík V, Kaul U, Guagliumi G, Chevalier B, Smits PC, Stuteville M, Li D, Sudhir K, Grube E. Džavík V, et al. Among authors: stuteville m. Catheter Cardiovasc Interv. 2013 Sep 1;82(3):E163-72. doi: 10.1002/ccd.24775. Epub 2013 May 3. Catheter Cardiovasc Interv. 2013. PMID: 23225766
SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomes.
Morice MC, Mikhail GW, Mauri i Ferré F, Modena MG, Strasser RH, Grinfeld L, Sudhir K, Stuteville M, Papeleu P, Li D, Rutledge D, Windecker S. Morice MC, et al. Among authors: stuteville m. EuroIntervention. 2012 Jul 20;8(3):325-35. doi: 10.4244/EIJV8I3A51. EuroIntervention. 2012. PMID: 22829508 Free article.
The SPIRIT V diabetic study: a randomized clinical evaluation of the XIENCE V everolimus-eluting stent vs the TAXUS Liberté paclitaxel-eluting stent in diabetic patients with de novo coronary artery lesions.
Grube E, Chevalier B, Guagliumi G, Smits PC, Stuteville M, Dorange C, Papeleu P, Kaul U, Džavík V. Grube E, et al. Among authors: stuteville m. Am Heart J. 2012 May;163(5):867-875.e1. doi: 10.1016/j.ahj.2012.02.006. Epub 2012 Apr 11. Am Heart J. 2012. PMID: 22607866 Clinical Trial.
The SPIRIT V study: a clinical evaluation of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with de novo coronary artery lesions.
Grube E, Chevalier B, Smits P, Džavík V, Patel TM, Mullasari AS, Wöhrle J, Stuteville M, Dorange C, Kaul U; SPIRIT V Investigators. Grube E, et al. Among authors: stuteville m. JACC Cardiovasc Interv. 2011 Feb;4(2):168-75. doi: 10.1016/j.jcin.2010.11.006. JACC Cardiovasc Interv. 2011. PMID: 21349455 Free article.
One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials.
de Ribamar Costa J Jr, Abizaid A, Bartorelli AL, Whitbourn R, Jepson N, Perin M, Steinwender C, Stuteville M, Ediebah D, Sudhir K, Serruys PW. de Ribamar Costa J Jr, et al. Among authors: stuteville m. EuroIntervention. 2016 Nov 20;12(10):1255-1262. doi: 10.4244/EIJV12I10A206. EuroIntervention. 2016. PMID: 27866134 Free article. Clinical Trial.
Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial.
Costa JR Jr, Abizaid A, Whitbourn R, Serruys PW, Jepson N, Steinwender C, Stuteville M, Ediebah D, Sudhir K, Bartorelli AL; ABSORB EXTEND investigators. Costa JR Jr, et al. Among authors: stuteville m. Catheter Cardiovasc Interv. 2019 Jan 1;93(1):E1-E7. doi: 10.1002/ccd.27715. Epub 2018 Oct 4. Catheter Cardiovasc Interv. 2019. PMID: 30286520 Clinical Trial.
12 results